Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Iveta Zapletalová"'
Autor:
Nina Zemanová, Kateřina Lněničková, Markéta Vavrečková, Eva Anzenbacherová, Pavel Anzenbacher, Iveta Zapletalová, Petra Hermanová, Tomáš Hudcovic, Hana Kozáková, Lenka Jourová
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, i
Externí odkaz:
https://doaj.org/article/ed4974ecba614f2a8fbb77eaf777a40a
Autor:
Hana Malinská, Martina Hüttl, Denisa Miklánková, Jaroslava Trnovská, Iveta Zapletalová, Martin Poruba, Irena Marková
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 9, p 4527 (2021)
Ovarian hormone deficiency leads to increased body weight, visceral adiposity, fatty liver and disorders associated with menopausal metabolic syndrome. To better understand the underlying mechanisms of these disorders in their early phases of develop
Externí odkaz:
https://doaj.org/article/84aa0be4704240099febee5600134310
Autor:
Aneta Grycová, Hansol Joo, Vítězslav Maier, Peter Illés, Barbora Vyhlídalová, Karolína Poulíková, Lucia Sládeková, Petr Nádvorník, Radim Vrzal, Lenka Zemánková, Petra Pečinková, Martin Poruba, Iveta Zapletalová, Rostislav Večeřa, Pavel Anzenbacher, Jiří Ehrmann, Peter Ondra, Jong-Wha Jung, Sridhar Mani, Zdeněk Dvořák
Publikováno v:
Journal of medicinal chemistry. 65(9)
Targeting the aryl hydrocarbon receptor (AhR) is an emerging therapeutic strategy for multiple diseases (e.g., inflammatory bowel disease).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f282e15f7eaad64d30b2eeac93914b7d
https://pubmed.ncbi.nlm.nih.gov/35416668
https://pubmed.ncbi.nlm.nih.gov/35416668
Autor:
Tomas Hudcovic, Pavel Anzenbacher, Lenka Jourova, Hana Kozakova, Nina Zemanová, Martin Vodička, Petra Hermanova, Jiří Pácha, Eva Anzenbacherova, Iveta Zapletalová
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports
Scientific Reports
The gut microbiota is involved in a number of different metabolic processes of the host organism, including the metabolism of xenobiotics. In our study, we focused on liver cytochromes P450 (CYPs), which can metabolize a wide range of exo- and endoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4ebf3bfcfaef3006aba5586efc358d
http://link.springer.com/article/10.1038/s41598-020-65595-9
http://link.springer.com/article/10.1038/s41598-020-65595-9
Autor:
Pavel Kosina, Eva Anzenbacherová, Barbora Szotáková, Lenka Skálová, Zuzana Racova, Jiří Prokop, Iveta Zapletalová, Pavel Anzenbacher, Tereza Lanickova, Norbert Cibiček, Kateřina Lněničková, Veronika Tománková, Lenka Jourova, Jitka Ulrichová
Publikováno v:
Food and Chemical Toxicology. 129:382-390
Vaccinium myrtillus L. (bilberry) fruit is a blue-colored berry with a high content of anthocyanins. These bioactive secondary metabolites are considered to play a major role in the health-promoting properties of bilberries. Our in vivo study was des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4c2f554954abe3064633671df712c4
https://doi.org/10.1016/j.fct.2019.04.051
https://doi.org/10.1016/j.fct.2019.04.051
Autor:
Pavel Kosina, Iveta Zapletalová, Eva Anzenbacherová, Jiří Prokop, Petr Martinek, Leoš Pavlata, Ondřej Šťastník, Pavel Anzenbacher, Eva Mrkvicová
Publikováno v:
Food and Chemical Toxicology. 122:225-233
Wheat is one of the most important agricultural crops worldwide. Recently, anthocyanin-rich wheat genotypes were introduced to the market as a food with added value. In the experiment described here, two different genotypes with blue grain were studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245fb71325a4c85a997f248bf03a4d7a
https://doi.org/10.1016/j.fct.2018.10.029
https://doi.org/10.1016/j.fct.2018.10.029
Autor:
Marketa Vavreckova, Kateřina Lněničková, Pavel Anzenbacher, Tomas Hudcovic, Nina Zemanová, Eva Anzenbacherová, Lenka Jourova, Hana Kozakova, Iveta Zapletalová, Petra Hermanova
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11, p e0259643 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11, p e0259643 (2021)
Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db7d61ac426e2c1169799ba0f764e24
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577747/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577747/?tool=EBI
Autor:
Veronika Frybortova, Stefan Satka, Lenka Jourova, Iveta Zapletalova, Martin Srejber, Philippe Briolotti, Martine Daujat-Chavanieu, Sabine Gerbal-Chaloin, Pavel Anzenbacher, Michal Otyepka, Eva Anzenbacherova
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3610 (2024)
As compounds of natural origin enter human body, it is necessary to investigate their possible interactions with the metabolism of drugs and xenobiotics in general, namely with the cytochrome P450 (CYP) system. Phytic acid (myo-inositol hexaphosphori
Externí odkaz:
https://doaj.org/article/8882ed7b9225490994babe3a277fa71b
Autor:
Martina Hüttl, Irena Markova, Denisa Miklánková, Iveta Zapletalova, Petr Kujal, Jan Šilhavý, Michal Pravenec, Hana Malinska
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and aims: Low-grade chronic inflammation plays an important role in the pathogenesis of metabolic syndrome, type 2 diabetes and their complications. In this study, we investigated the effects of salsalate, a non-steroidal anti-inflammatory
Externí odkaz:
https://doaj.org/article/43d18ec3736b4092867a31a16cc3da06
Autor:
Lenka Jourova, Stefan Satka, Veronika Frybortova, Iveta Zapletalova, Pavel Anzenbacher, Eva Anzenbacherova, Petra Petr Hermanova, Barbora Drabonova, Dagmar Srutkova, Hana Kozakova, Tomas Hudcovic
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The development of inflammatory bowel disease (IBD) is associated with alterations in the gut microbiota. There is currently no universal treatment for this disease, thus emphasizing the importance of developing innovative therapeutic approaches. Gut
Externí odkaz:
https://doaj.org/article/354778228db1423bae3af4090715a4c2